What is the long-term trend for Corcept Therapeutics's increase decrease in other accrued liabilities?

Over 2 years (2021 to 2024), Corcept Therapeutics's increase decrease in other accrued liabilities has grown at a 146.8% compound annual growth rate (CAGR), from $6.48M to $39.45M.

Corcept Therapeutics CORT Increase Decrease In Other Accrued Liabilities

Increase Decrease In Other Accrued Liabilities at other companies

GlaukosGKOS

-$2.25M-106%

NiSourceNI

-$16.9M+40.9%

ACM ResearchACMR

$9.42M+15.4%

Advanced Energy IndustriesAEIS

$46.6M+144%

Baxter InternationalBAX

$203M+42.0%

Genuine PartsGPC

$79.88M+645%

Other financials

Income statement

See full

Revenue$164.9M+4.9%

Gross profit$162.0M+4.7%

Operating income-$49.6M-1,552%

Net income-$31.8M-255%

EPS (diluted)-$0.30-276%

Balance sheet

See full

Cash & equivalents$110.0M+21.1%

Total debt$9.6M+41.0%

Total equity$638.0M-6.6%

Total assets$814.9M-3.7%

Cash flow

See full

Operating cash flow-$16.8M-452%

CapEx$201.0K+93.3%

Free cash flow-$17.0M-464%

Valuation

See full

Market cap$8.58B-64.4%

Enterprise value$8.48B-65.0%

P/E181.2×+1.3×

P/S11.2×-24.0×

Profitability

See full

Gross margin98.3%-0.2pp

Operating margin-1.1%-17.2pp

Net margin6.2%-13.4pp

FCF margin15.6%-10.2pp

Returns & leverage

See full

Return on equity7.2%-14.6pp

Debt / equity0×0.0×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Corcept Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's increase decrease in other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corcept Therapeutics's increase decrease in other accrued liabilities?: Corcept Therapeutics (CORT) reported increase decrease in other accrued liabilities of -$9.38M in Q1 2026.
How has Corcept Therapeutics's increase decrease in other accrued liabilities changed year-over-year?: Corcept Therapeutics's increase decrease in other accrued liabilities decreased by 57.9% year-over-year, from -$5.94M to -$9.38M.
What is the long-term trend for Corcept Therapeutics's increase decrease in other accrued liabilities?: Over 2 years (2021 to 2024), Corcept Therapeutics's increase decrease in other accrued liabilities has grown at a 146.8% compound annual growth rate (CAGR), from $6.48M to $39.45M.